A new biotechnology company in Chile: PerOs Aquatic

10-Aug-2005

PerOs Systems Technologies announced the establishment of its worldwide aquaculture division, PerOs Aquatic Limitada. This new Chilean biotechnology company will be using PerOs' patented Oralject(TM) technology to address major health concerns in the aquaculture market.

Oralject(TM) is a technology that permits the oral delivery of a variety of therapeutic molecules, including antigens, peptides and nutraceuticals. Oralject(TM) can be combined with these prescribed bioactive compounds and administered at virtually any stage of a fish's growth cycle. This unique drug delivery technology will allow PerOs Aquatic to offer unprecedented protection to fish crops. Unlike injectable drug delivery methods, PerOs' Oralject(TM) technology allows fish to be protected in any field situation.

Over the next few years, PerOs Aquatic will be introducing a range of new Oralject(TM) technology applications, and Chile will be the first country in the world to have access to these solutions.

PerOs Aquatic's veterinary specialists will work directly with Chilean fish producers to evaluate health problems encountered at their installations and develop customized treatments that take advantage of the flexibility of PerOs' Oralject(TM) technology. Based on these cooperative ventures, PerOs Aquatic will continue to develop and manufacture Oralject(TM) applications that will impact the aquaculture industry throughout the world.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance